These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 313084)

  • 21. Current concepts in the management of hemophilia.
    Abildgaard CF
    Semin Hematol; 1975 Jul; 12(3):223-32. PubMed ID: 1079631
    [No Abstract]   [Full Text] [Related]  

  • 22. Extractions in hemophilia. Use of EACA.
    Short SG; Ogle RG
    Minn Med; 1974 Feb; 57(2):77-80. PubMed ID: 4544337
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases.
    Marder VJ; Gamble JW; Shulman NR
    J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
    Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
    Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
    [No Abstract]   [Full Text] [Related]  

  • 26. [Our experiences with tooth extraction in patient with hemophilia].
    Perovic J; Obradovic O; Stefanovic S
    Minerva Stomatol; 1969 Jan; 18(1):32-3. PubMed ID: 5305771
    [No Abstract]   [Full Text] [Related]  

  • 27. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
    DiMichele D; Kroner B;
    Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic infusion regimens in the management of hemophilia.
    Ljung RC
    Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Sjögren's syndrome predispose surgical patients to acquired hemophilia?
    Dachman AF; Margolis H; Aboulafia E
    J Am Osteopath Assoc; 1995 Feb; 95(2):115-8, 121. PubMed ID: 7534284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 31. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor.
    Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foundations of hemophilia and epidemiology.
    Quintana Paris L
    Blood Coagul Fibrinolysis; 2023 Jun; 34(S1):S35-S36. PubMed ID: 37254731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New plasma derivatives].
    Soulier JP
    Rev Prat; 1972 Mar; 22(9):1465-6 passim. PubMed ID: 4119093
    [No Abstract]   [Full Text] [Related]  

  • 35. [Algostat therapy of patients with hemophilia].
    Vygovskaia IaI; Kharchenko IA
    Vrach Delo; 1971 Apr; 7():57-61. PubMed ID: 5140133
    [No Abstract]   [Full Text] [Related]  

  • 36. [Episilon-aminocaproic acid in the therapy of hemophilia].
    Gobbi F
    Clin Ter; 1968 Jul; 46(1):55-72. PubMed ID: 4883513
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
    Berntorp E; Astermark J; Carlborg E
    Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regimens of factor VIII administration--continuous infusion vs. bolus.
    Berntorp E
    Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG].
    Foltyn H; Wróbel I
    Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peculiarities of the clinical picture and treatment of hematuria in patients with hemophilia].
    Papain LP; Aksenov NA; Fedorova ZD; Alekseev RA; Volkova SD
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):27-30. PubMed ID: 1273060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.